Incidence, Predictors and Prognosis of Acute Kidney Injury in Acute ST-segment Elevation Myocardial Infarction Patients Undergoing Emergent Coronary Angiography/primary Percutaneous Coronary Intervention

Overview

Journal J Geriatr Cardiol

Specialty Geriatrics

Date 2023 Mar 13

PMID 36910244

Authors

Jing Tan

Ying-Hua Zhang

Jin Si

Ke-Ling Xiao

Qi Hua

Jing Li

Affiliations

Soon will be listed here.

Abstract

Background: Acute kidney injury (AKI) after coronary angiography (CAG) and primary percutaneous coronary intervention (PPCI) is frequently observed, and often interpreted as contrast induced-AKI. This study aimed to investigate the incidence, predictors and outcomes of AKI in acute ST-segment elevation myocardial infarction (STEMI) patients undergoing emergent CAG/PPCI using the control group of STEMI patients who were not exposed to contrast agents within the first 72 h.

Methods: We performed a retrospective analysis of 1670 STEMI patients. Of them, 673 patients underwent emergent CAG/PPCI, and 997 patients treated with thrombolysis or no reperfusion therapy who were not exposed to contrast material during the first 72 h. AKI was defined as an increase of serum creatinine ≥ 44.2 mmol/L or ≥ 25% from baseline within 72 h. Patents were then followed up for the occurrence of all-cause mortality for 40 months (interquartile range: 24-55 months).

Results: After propensity score matching, 505 pairs of patients were matched. Overall, the incidence of AKI was 27.4%, and AKI rates were not significantly different in patients with and without emergent CAG/PPCI procedure (27.5% 27.3%, = 0.944). Multivariate logistic regression analysis identified that the independent predictors of AKI were female, elevated interleukin-6 level, decreased lymphocyte count, left ventricular ejection fraction < 50% and use of diuretics in patients with emergent CAG/PPCI. Patients with AKI than those without AKI experienced higher incidence of acute heart failure with Killip class III (9.4% 3.3%, = 0.005; 15.2% 6.8%, = 0.003, respectively) and mortality (5.8% 1.4%, = 0.014; 12.3% 4.6%, = 0.002, respectively) in patients with and without emergent CAG/PPCI. Multivariate Cox regression analysis confirmed that AKI was independently associated with long-term mortality rate at 40 months follow-up in patients with and without emergent CAG/PPCI (HR = 1.867, 95% CI: 1.086-3.210, = 0.024; HR = 1.700, 95% CI: 1.219-2.370, = 0.002, respectively).

Conclusions: Approximately 27.0% of STEMI patients experience AKI, which is strongly associated with an increased short- and long-term mortality regardless of emergent CAG/PPCI procedure. The development of AKI is mainly related to female gender, inflammation reaction, heart failure and use of diuretics in STEMI patients undergoing emergent CAG/PPCI.

References

Levey A, Inker L, Coresh J . GFR estimation: from physiology to public health. Am J Kidney Dis. 2014; 63(5):820-34. PMC: 4001724. DOI: 10.1053/j.ajkd.2013.12.006. View

Patschan D, Patschan S, Buschmann I, Ritter O . Loop Diuretics in Acute Kidney Injury Prevention, Therapy, and Risk Stratification. Kidney Blood Press Res. 2019; 44(4):457-464. DOI: 10.1159/000501315. View

Kumar D, Liaquat H, Sial J, Saghir T, Kumari R, Kumar H . Risk Factors Associated With Contrast-Induced Nephropathy after Primary Percutaneous Coronary Intervention. Cureus. 2020; 12(8):e9721. PMC: 7489321. DOI: 10.7759/cureus.9721. View

Narula A, Mehran R, Weisz G, Dangas G, Yu J, Genereux P . Contrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudy. Eur Heart J. 2014; 35(23):1533-40. DOI: 10.1093/eurheartj/ehu063. View

Gohbara M, Hayakawa A, Akazawa Y, Furihata S, Kondo A, Fukushima Y . Association Between Acidosis Soon After Reperfusion and Contrast-Induced Nephropathy in Patients With a First-Time ST-Segment Elevation Myocardial Infarction. J Am Heart Assoc. 2017; 6(8). PMC: 5586466. DOI: 10.1161/JAHA.117.006380. View

Caspi O, Habib M, Cohen Y, Kerner A, Roguin A, Abergel E . Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit?. J Am Heart Assoc. 2017; 6(6). PMC: 5669180. DOI: 10.1161/JAHA.117.005715. View

He H, Chen X, Chen Y, Niu T, Liao Y . Prevalence and Predictors of Contrast-Induced Nephropathy (CIN) in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI): A Meta-Analysis. J Interv Cardiol. 2019; 2019:2750173. PMC: 6854223. DOI: 10.1155/2019/2750173. View

Markousis-Mavrogenis G, Tromp J, Ouwerkerk W, Devalaraja M, Anker S, Cleland J . The clinical significance of interleukin-6 in heart failure: results from the BIOSTAT-CHF study. Eur J Heart Fail. 2019; 21(8):965-973. DOI: 10.1002/ejhf.1482. View

Senoo T, Motohiro M, Kamihata H, Yamamoto S, Isono T, Manabe K . Contrast-induced nephropathy in patients undergoing emergency percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2010; 105(5):624-8. DOI: 10.1016/j.amjcard.2009.10.044. View

10.

Khalfallah M, Allaithy A, Maria D . Incidence, Predictors and Outcomes of Contrast Induced Nephropathy in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Glob Heart. 2021; 16(1):57. PMC: 8415176. DOI: 10.5334/gh.1071. View

11.

Fanola C, Morrow D, Cannon C, Jarolim P, Lukas M, Bode C . Interleukin-6 and the Risk of Adverse Outcomes in Patients After an Acute Coronary Syndrome: Observations From the SOLID-TIMI 52 (Stabilization of Plaque Using Darapladib-Thrombolysis in Myocardial Infarction 52) Trial. J Am Heart Assoc. 2017; 6(10). PMC: 5721825. DOI: 10.1161/JAHA.117.005637. View

12.

Butt K, DSouza J, Yuan C, Jayakumaran J, Nguyen M, Butt H . Correlation of the Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) with Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Interventions. Cureus. 2021; 12(12):e11879. PMC: 7781777. DOI: 10.7759/cureus.11879. View

13.

Nechemia-Arbely Y, Barkan D, Pizov G, Shriki A, Rose-John S, Galun E . IL-6/IL-6R axis plays a critical role in acute kidney injury. J Am Soc Nephrol. 2008; 19(6):1106-15. PMC: 2396933. DOI: 10.1681/ASN.2007070744. View

14.

Mehran R, Aymong E, Nikolsky E, Lasic Z, Iakovou I, Fahy M . A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44(7):1393-9. DOI: 10.1016/j.jacc.2004.06.068. View

15.

Wi J, Ko Y, Kim J, Kim B, Choi D, Ha J . Impact of contrast-induced acute kidney injury with transient or persistent renal dysfunction on long-term outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention. Heart. 2011; 97(21):1753-7. DOI: 10.1136/hrt.2010.218677. View

16.

Nemoto N, Iwasaki M, Nakanishi M, Araki T, Utsunomiya M, Hori M . Impact of continuous deterioration of kidney function 6 to 8 months after percutaneous coronary intervention for acute coronary syndrome. Am J Cardiol. 2014; 113(10):1647-51. DOI: 10.1016/j.amjcard.2014.02.019. View

17.

Koowattanatianchai S, Chantadansuwan T, Kaladee A, Phinyo P, Patumanond J . Practical Risk Stratification Score for Prediction of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation Myocardial Infarction. Cardiol Res. 2019; 10(6):350-357. PMC: 6879045. DOI: 10.14740/cr939. View

18.

Tsai T, Patel U, Chang T, Kennedy K, Masoudi F, Matheny M . Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry. JACC Cardiovasc Interv. 2014; 7(1):1-9. PMC: 4122507. DOI: 10.1016/j.jcin.2013.06.016. View

19.

Frydman S, Freund O, Banai A, Zornitzki L, Banai S, Shacham Y . Relation of Gender to the Occurrence of AKI in STEMI Patients. J Clin Med. 2022; 11(21). PMC: 9655780. DOI: 10.3390/jcm11216565. View

20.

Yuan Y, Qiu H, Hu X, Luo T, Gao X, Zhao X . Risk Factors of Contrast-induced Acute Kidney Injury in Patients Undergoing Emergency Percutaneous Coronary Intervention. Chin Med J (Engl). 2017; 130(1):45-50. PMC: 5221111. DOI: 10.4103/0366-6999.196578. View